| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b9ae3e22b19cd6cd575b4ecf5d77419 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-003 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08 |
| filingDate |
2020-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112375158-A |
| titleOfInvention |
Chitosan-based nano-drug carrier and preparation method thereof |
| abstract |
The invention provides a chitosan-based nano-drug carrier and a preparation method thereof, belonging to the technical field of biomedical materials. The chitosan-based nano-drug carrier and the preparation method thereof provided by the invention have the advantages of long-acting circulation in vivo, high-efficiency targeting on tumors, improvement on the bioavailability of the drug and lower production cost. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113896812-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114984238-A |
| priorityDate |
2020-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |